- Home
- EVF vs VOR Comparison
EVF vs VOR Comparison
Compare EVF & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVF
- VOR
- Stock Information
- Founded
- EVF 1998
- VOR 2015
- Country
- EVF United States
- VOR United States
- Employees
- EVF N/A
- VOR N/A
- Industry
- EVF Investment Managers
- VOR Biotechnology: Pharmaceutical Preparations
- Sector
- EVF Finance
- VOR Health Care
- Exchange
- EVF Nasdaq
- VOR Nasdaq
- Market Cap
- EVF 102.2M
- VOR 85.7M
- IPO Year
- EVF N/A
- VOR 2021
- Fundamental
- Price
- EVF $5.69
- VOR $0.16
- Analyst Decision
- EVF
- VOR Buy
- Analyst Count
- EVF 0
- VOR 7
- Target Price
- EVF N/A
- VOR $7.83
- AVG Volume (30 Days)
- EVF 93.3K
- VOR 1.8M
- Earning Date
- EVF 01-01-0001
- VOR 05-20-2025
- Dividend Yield
- EVF 10.68%
- VOR N/A
- EPS Growth
- EVF N/A
- VOR N/A
- EPS
- EVF 0.94
- VOR N/A
- Revenue
- EVF N/A
- VOR N/A
- Revenue This Year
- EVF N/A
- VOR N/A
- Revenue Next Year
- EVF N/A
- VOR N/A
- P/E Ratio
- EVF $6.74
- VOR N/A
- Revenue Growth
- EVF N/A
- VOR N/A
- 52 Week Low
- EVF $5.20
- VOR $0.15
- 52 Week High
- EVF $6.84
- VOR $1.87
- Technical
- Relative Strength Index (RSI)
- EVF 54.81
- VOR 16.97
- Support Level
- EVF $5.60
- VOR $0.13
- Resistance Level
- EVF $5.73
- VOR $0.85
- Average True Range (ATR)
- EVF 0.07
- VOR 0.06
- MACD
- EVF 0.02
- VOR -0.05
- Stochastic Oscillator
- EVF 86.67
- VOR 4.46
About EVF Eaton Vance Senior Income Trust
Eaton Vance Senior Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to provide a high level of current income consistent with the preservation of capital, by investing in senior, secured floating-rate loans. The trust invests in below-investment-grade floating-rate loans, which are considered speculative because of the credit risk of their issuers. Its portfolio of investment consists of aerospace and defense, automotive, beverage, building and development, business equipment and services, cable and satellite television, and other areas.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.